In the title compound, C 13 H 9 ClINO 4 S, the dihedral angle between the aromatic rings is 81. 04 (17) . The disposition of the I and Cl atoms attached to the two rings is anti. In the crystal, molecules are connected via O-HÁ Á ÁO and N-HÁ Á ÁO hydrogen bonds.
Related literature
For background to thiazine heterocycles, see: Arshad et al. (2008 Arshad et al. ( , 2011 . For their biological activity, see: Medina et al. (1999) . For related structures, see: Arshad et al. (2009a,b,c) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
Comment
The title compound, (I), is an example of a halogenated sulfonamide, which are reported as inhibitors for the growth of multidrug resistant MCF-7/ADR cancer cells (Medina et al., 1999) . In continuation to our researches with sulfonamides (Arshad et al., 2009a) , the title compound has been prepared, as an intermediate for the preparation of thiazine related heterocycles (Arshad et al., 2008 (Arshad et al., , 2011 .
The crystal structure of (I) being reported here as an isomer of previously reported compound 2-chloro-5-(2-iodobenzenesulfonamido)benzoic acid (II), (Arshad, et al., 2009a) . The bond lengths and bond angles are also compareable with the 5-benzenesulfonamido-2-chlorobenzoic acid (III), (Arshad, et al., 2009b) 
Experimental
The title compound was prepared following the method of Arshad et al. (2009a) . Red needles were recrystallised from methanol.
Refinement
All the H-atoms were positioned with idealized geometry with C-H = 0.93 Å, N-H = 0.86 Å, O-H = 0.82 Å and were refined using a riding model with U iso (H) = 1.2 U eq for aromatic C and N atoms and with U iso (H) = 1.5 U eq for O atom. Figures   Fig. 1 . The structure of (I) with displacement ellipsoids drawn at the 50% probability level.
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